Although AR is the classical target for prostate cancer prevention and treatment, several recent studies indicated that estrogen and estrogen receptor (ER) have also been implicated in prostate cancer development, prostate cancer cell stemness, and tumor progression [8,9]. The gene discussed is AR; the disease is Familial prostate cancer.